Submitted by Anonymous (not verified) on 16 September 2026 - 15:58
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 10, Status: Authorised